CFH nonsense mutation-mediated pregnancy-associated atypical hemolytic uremic syndrome: Case report
Molecular Immunology · 2025
DOI: 10.1016/j.molimm.2025.07.002 ↗Kurz gefasst
Fallbericht in der Zeitschrift Molecular Immunology, 2025. Verfasst von Chengjun Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Affiliated Jiangyin Hospital of Nantong University, Jiangyin, Jiangsu, China. Hauptthemen laut MEDLINE: Complement Factor H, Pregnancy Complications, Atypical Hemolytic Uremic Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Pregnancy-associated hemolytic uremic syndrome (P-aHUS) is characterized by microvascular hemolytic anemia, thrombocytopenia, and acute organ damage, particularly acute kidney injury, occurring during pregnancy or in the postpartum period. This rare disease has been associated with mutations in genes that regulate the complement system in most reported cases. This article introduces a 38-year-old maternal, who gave birth again after 13 years. Approximately four days post-cesarean section, she developed severe anemia, thrombocytopenia, renal impairment, and abnormal liver function, prompting urgent symptomatic treatment by the doctor. Subsequent detections revealed decreased complement C3 levels, a negative result for the ADAMTS13 inhibitory antibody, and a negative stool culture for bacterial fungi. The diagnosis of P-aHUS was confirmed, and the condition was successfully managed with complement blockade therapy using Eculizumab. Genetic sequencing of the complement factor H (CFH) gene revealed the c.3643 C > T mutation (p.Arg1215*), indicating the presence of rare CFH gene variants that may contribute to the patient's condition. These findings elucidate the clinical manifestations and treatment responses associated with the rare disease P-aHUS in relation to specific gene mutations. We underscore the significance of genetic testing for accurate diagnosis and personalized treatment, offering new insights and evidence for the future clinical management and research of similar cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The Affiliated Jiangyin Hospital of Nantong University, Jiangyin, Jiangsu, China.
- Suzhou Jsuniwell Medical Laboratory, Suzhou, China.
- Suzhou Medical College of Soochow University, Suzhou, China.
- Suzhou Jsuniwell Medical Laboratory, Suzhou, China. Electronic address: ping_chen@fujidabio.com.
- Department of Hematology, The Affiliated Jiangyin Hospital of Nantong University, Jiangyin, Jiangsu, China. Electronic address: xumaozhongjy@163.com.
Zitieren
APA
Hu, C., Zhang, P., Xu, Q., Qin, R., Chen, W., Shi, Z., Chen, P., & Xu, M. (2025). CFH nonsense mutation-mediated pregnancy-associated atypical hemolytic uremic syndrome: Case report. Molecular Immunology. https://doi.org/10.1016/j.molimm.2025.07.002
Vancouver
Hu C, Zhang P, Xu Q, Qin R, Chen W, Shi Z, et al. CFH nonsense mutation-mediated pregnancy-associated atypical hemolytic uremic syndrome: Case report. Molecular Immunology. 2025. doi:10.1016/j.molimm.2025.07.002
BibTeX
@article{Hu2025,
author = {Hu, Chengjun and Zhang, Ping and Xu, Qi and Qin, Rujuan and Chen, Weifeng and Shi, Zhen and Chen, Ping and Xu, Maozhong},
title = {CFH nonsense mutation-mediated pregnancy-associated atypical hemolytic uremic syndrome: Case report},
journal = {Molecular Immunology},
year = {2025},
doi = {10.1016/j.molimm.2025.07.002}
}
EUVIMED